Seeking Alpha

Bayer HealthCare completes the acquisition of Teva's (TEVA +0.1%) U.S.-based animal health...

Bayer HealthCare completes the acquisition of Teva's (TEVA +0.1%) U.S.-based animal health business after receiving the necessary regulatory approvals. Teva will receive up to $145M following the achievement of manufacturing and sales targets. The sale is no doubt part of the Israeli company's restructuring.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs